Citation tools
"Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.." The Journal of Rheumatology
35.2
(2008):
201-205.
Web. 17 Sept2024.